Epacadostat is a small molecule commercialized by Incyte, with a leading Phase II program in Salivary Gland Cancer.
NIH-funded clinical trials often miss racial, gender diversity enrollment goals, report finds
WASHINGTON — Clinical trials that the National Institutes of Health funds often enroll fewer Black patients and other underrepresented racial groups than they plan to,